The increased need for more effective treatments for diseases of the eye such as glaucoma, macular degeneration and dry eye, coupled with technological advances in areas such as regenerative medicine, are providing exciting opportunities for companies to develop new eye care products.
This webcast will explore some of the latest advances in the ophthalmic field through discussion with representatives from companies developing a range of innovative therapies for eye disorders, including the use of iPS cells, eye drops to deliver small-molecule drugs and complement inhibition.
The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to participate and put your own questions to the speakers.
